CClinicalTrials.gg
CompletedNCT06154850Updated Mar 27, 2024

Effects of Virtual Reality on Brain Hemodynamic Activity in Chronic Pain

An interventional study of Immersive virtual reality and Non-immersive virtual reality in Chronic Pain, Rheumatoid Arthritis and Virtual Reality, sponsored by Acibadem University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2024-03-27.

Sponsored by Acibadem University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Virtual reality systems have been applied in recent years to reduce pain intensity and fear of movement in individuals with acute and chronic pain. The main mechanism of virtual reality methods in pain control is to provide the effect of distraction from pain. Virtual reality systems allow the individuals to feel themselves in a different environment and shift their attention to the game they are playing or the virtual world created rather than the pain they feel. This is thought to be the main mechanism of pain control. However, the cortical mechanism of the reduction in pain caused by virtual reality methods, especially in individuals with chronic pain, has not been fully elucidated.

It is predicted that the integration of virtual reality methods into treatment protocols will gradually increase by time, especially as a result of the reflection of technological developments in clinical practice. At this point, fNIRS, which enables the assessment of the functionality of brain areas during movement, has the potential to reveal the response of the effect provided by virtual reality technology in the prefrontal cortex.

The aims of our study were to examine brain hemodynamic activity during the experience of non-immersive and immersive virtual reality environments and the change in pain intensity after virtual reality applications in individuals with rheumatic diseases with chronic pain.

02

Conditions studied

  • Chronic Pain
  • Rheumatoid Arthritis
  • Virtual Reality

Browse trials for

03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 699 are open to participants now.

This study's enrollment of 15 is below the median of 60 across 2,160 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Acibadem University is the lead sponsor of 210 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with rheumatoid arthritis,
  • Right hand dominant,

Exclusion criteria

Exclusion criteria:

  • A history of acute pain up to 3 days prior to the date of evaluation,
  • Any psychiatric and neurological diagnosis,
  • Have a cognitive problem that prevents them from adapting to the working procedure,
  • Using centrally acting medications and anti-depressants.
  • Presence of neuropathic pain,
  • Presence of vision or hearing problems,
  • Any psychiatric and neurological diagnosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Immersive Virtual Reality

    Individuals will wear the headset for 10 minutes while playing NatureTrek application

    Other: Immersive virtual reality

  • Active comparator
    Non-immersive Virtual Reality

    Individuals will watch a video including scenes from NatureTrek application for 10 minutes.

    Other: Non-immersive virtual reality

Interventions

  • OtherImmersive virtual reality

    Oculus Quest 2 will be used with NatureTrek application for 10 minutes.

  • OtherNon-immersive virtual reality

    Patients will watch a video including scenes from NatureTrek application on a screen.

06

What researchers measure

Primary outcomes

  1. Functional near infrared spectrosopy

    Real-time measurement and monitoring of brain hemodynamics will be performed with a 24-channel fNIRS device (Brite 24, Artinis, The Netherlands). Recordings will be obtained with sensors placed in the prefrontal cortex. In the study design, after the sensors are placed on the scalp, a 1-minute recording will first be taken in the resting position. Afterwards, painful and painless mechanical stimuli will be given to the subjects during the viewing of fully immersive and non-immersive virtual reality environments.

    Time frame: During the intervention

  2. Numeric Pain Rating Scale

    Numeric Pain Rating Scale will be used to quantify pain severity after both virtual reality applications. Patients will be asked to report their pain numerically as 0: no pain; 10: unbearable pain.

    Time frame: Immediately after the intervention

Secondary outcomes

  1. Perceived Level of Fun

    The level of entertainment perceived by the participants after each virtual reality application will be evaluated on a scale of 0 to 10 (0 = not entertained at all, 10 = very entertained).

    Time frame: Immediately after the intervention

  2. Heart rate variability

    Heart rate variability will be assessed using a wearable belt (Polar OH1 heart rate monitor).

    Time frame: During the intervention

Other outcomes

  1. Pain Catastrophizing Scale

    Pain Catastrophizing Scale assesses catastrophic feelings associated with pain, is a Likert-type self-assessment scale consisting of 13 items rated between 0 and 4 points. The total score ranges from 0 to 52 and includes rumination, magnification and helplessness subscales. Higher scores on the scale indicate higher levels of pain catastrophizing.

    Time frame: Pre-intervention

  2. Tampa Kinesiophobia Scale

    Tampa Kinesiophobia Scale consists of 17 questions and is used to assess fear and avoidance behaviors in diseases related to musculoskeletal injuries. The scale uses a 4-point Likert scoring system (1=strongly disagree and 4=strongly agree). The total score is calculated after reversing questions 4, 8, 12 and 16 and ranges from 17 to 68. Higher scores indicate higher levels of kinesiophobia.

    Time frame: Pre-intervention

  3. Adverse effects

    VR related events included dizziness, nausea, eye strain, and seizure.

    Time frame: Immediately after the intervention

  4. Pain Detect Questionnaire

    PainDETECT is a validated self-report tool to identify neuropathic pain features in a range of conditions. Pain Detect Questionnaire consists of 17 questions, and the maximum score is 30. Scores equal or above 19 indicate the presense of likely neuropathic pain.

    Time frame: Pre-intervention

07

Study locations

1 site
  • Acıbadem Mehmet Ali Aydınlar University
    Istanbul, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06154850
Lead sponsor
Acibadem University
Collaborators
Kartal Dr. Lütfi Kirdar City Hospital
Responsible party
Sponsor
First posted
Dec 4, 2023
Start date
Nov 7, 2023
Primary completion
Mar 10, 2024
Completion
Mar 19, 2024
Last update
Mar 27, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion